U.S. Electric Utilities Stock News

Recent interest in NVE (NVEC) has picked up after Semitech was appointed an authorized distributor for the company’s isolation products. The move is aimed at widening access to its digital isolation solutions in the U.S. See our latest analysis for NVE. NVE’s recent distributor agreement with Semitech and the latest full year results, which showed revenue of US$26.33 million and net income of US$15.2 million, have coincided with strong momentum. This includes a 30 day share price return of...

Omeros Corporation reported past first-quarter 2026 results showing sales of US$9.89 million and a shift from a net loss to net income of US$56.06 million, with both basic and diluted earnings per share turning positive versus the prior year. Beyond the headline profit swing, the quarter reflects earnings power influenced by noncash items and comes alongside ongoing regulatory and clinical momentum for YARTEMLEA and the broader complement pipeline. We’ll now examine how this sharp earnings...

Venture Global (VG) opened Q1 2026 with revenue of US$4.6 billion and basic EPS of US$0.22, setting the tone for how investors will read the latest move in both the top and bottom line. Over the past year, the company has seen quarterly revenue move from US$2,894 million in Q1 2025 to US$4,599 million in Q1 2026, while basic EPS shifted from US$0.17 to US$0.22 across the same periods, giving a clear sense of how sales and per share profitability are tracking into the new fiscal year. With...

Wondering if Pegasystems at around US$32.72 is a bargain or a value trap? This article walks through the key numbers you need to size that up. The stock is down about 10% over the past week, 21.3% over the past month, 41.6% year to date and 33% over the past year. The 3-year return sits at 49.6%, and the 5-year return is down 43.9%. Recent headlines around Pegasystems have focused on its position within the software sector and shifting sentiment toward growth oriented platforms. This helps...

Investors considering Global-E Online at around US$27.54 may be wondering whether the stock is starting to look attractive or if the recent weakness is a warning sign. This article focuses on what the current price might imply about value. The stock has retreated recently, with returns down 11.8% over the last week, 9.8% over the last month, 27.3% year to date and 19.7% over the past year. Recent news around Global-E Online has centered on its role as a cross border e-commerce enablement...

Madison Air Solutions (MAIR) has quickly come onto investors’ radar after completing the largest U.S. industrial IPO in nearly three decades, followed by strong Q1 2026 results and confident full year sales guidance. See our latest analysis for Madison Air Solutions. Since the April IPO, investor interest has translated into a 1 day share price return of 3.5%, a 7 day share price return of 7.3%, and a year to date share price return of 33.9% at a last close of $42.50. This suggests momentum...

Giftify’s (NASDAQ:GIFT) reported 25% gross billings growth to US$45 million in Q1 2026 as CardCash buy orders, average order value, and new seller acquisition reached multi-year highs.

Avidia Bancorp, Inc. ( NYSE:AVBC ) is about to trade ex-dividend in the next 4 days. The ex-dividend date occurs one...

Investors in Circle Internet Group, Inc. ( NYSE:CRCL ) had a good week, as its shares rose 3.9% to close at US$127...

Even though Resolute Holdings Management, Inc. ( NYSE:RHLD ) posted strong earnings, investors appeared to be...

Readers hoping to buy Concentra Group Holdings Parent, Inc. ( NYSE:CON ) for its dividend will need to make their move...

LandBridge Company LLC ( NYSE:LB ) just reported healthy earnings but the stock price didn't move much. We think that...

The subdued stock price reaction suggests that Loar Holdings Inc.'s ( NYSE:LOAR ) strong earnings didn't offer any...

PACS Group, Inc. ( NYSE:PACS ) investors will be delighted, with the company turning in some strong numbers with its...

Shareholders appeared unconcerned with Crane NXT, Co.'s ( NYSE:CXT ) lackluster earnings report last week. Our analysis...

As you might know, Septerna, Inc. ( NASDAQ:SEPN ) just kicked off its latest quarterly results with some very strong...

Traeger, Inc. ( NYSE:COOK ) shareholders are probably feeling a little disappointed, since its shares fell 2.7% to...

The most recent earnings report from ESAB Corporation ( NYSE:ESAB ) was disappointing for shareholders. While the...

Some Cipher Digital Inc. ( NASDAQ:CIFR ) shareholders may be a little concerned to see that the Independent Director...

High inflation risks, sticky interest rates and energy driven cost pressures have pushed many investors toward income they can see and touch. That is where the Dividend Fortresses screener comes in, focusing on stocks with dividend yields above 5% that aim to offer both resilience and meaningful cash payouts. Instead of trying to guess the next macro twist, you can look at companies that already return a high share of cash to shareholders. In this article you will see three stocks from the...

Patria Investments Limited ( NASDAQ:PAX ) stock is about to trade ex-dividend in three days. The ex-dividend date is...

Gold Royalty (GROY) has attracted attention after reporting first quarter 2026 earnings with sales of US$7.18 million and net income of US$1.77 million, a shift from a loss in the prior year period. See our latest analysis for Gold Royalty. The share price sits at US$3.73, with a 7 day share price return of 5.97% and a 90 day share price return that is down 11.19%. The 1 year total shareholder return of 152.03% indicates strong longer term momentum despite recent volatility and follows...

BioCryst Pharmaceuticals (NasdaqGS:BCRX) has granted Neopharmed Gentili exclusive European licensing rights to navenibart for hereditary angioedema. The agreement includes an upfront payment and potential future milestone payments to BioCryst. Neopharmed Gentili is expected to use its existing European commercial infrastructure to support the rollout of navenibart. At ISPOR 2026, BioCryst presented real world evidence on pediatric hereditary angioedema highlighting ongoing medical and...

Harmony Biosciences Holdings, Inc.'s ( NASDAQ:HRMY ) earnings announcement last week didn't impress shareholders...